Venom Biotechnology • Biomedical Research • Ethiopia

Unlocking the potential of scorpion venom

Ethiopia scorpion breeding, venom production and biomedical research.

Our visionPartner with us
Development stage. MEDHIN is developing a controlled scorpion breeding and venom-production platform designed to support pharmaceutical and biomedical research. Regulated commercial activities remain subject to Ethiopian governmental authorization.
Scientific identityVenom Biotechnology & Research
Controlled BreedingCaptive population development
Venom ResearchPlanned collection under authorization
Biomedical FocusResearch & pharmaceutical development
Regulatory FirstApprovals before regulated operations
About MEDHIN

A scientific platform being developed from Ethiopia.

MEDHIN is a proposed Ethiopian venom-biotechnology and research initiative centered on responsible captive scorpion breeding, controlled husbandry, planned venom production and scientific collaboration. The project is designed to build a foundation for legitimate pharmaceutical, biomedical and toxinology research while respecting Ethiopian regulatory requirements and wildlife-conservation principles.

Why MEDHIN was established

Building local scientific capacity

MEDHIN is being developed around the idea that Ethiopia can strengthen its contribution to biomedical and pharmaceutical research by building specialized local capability in venom biology, controlled animal husbandry, laboratory documentation and research collaboration.

The concept also recognizes the importance of scientific research and wildlife conservation: responsible captive breeding may support species-preservation objectives by reducing unnecessary pressure on wild populations, subject to appropriate scientific and regulatory guidance.

Ethiopia as the operating base

A platform rooted in Ethiopia

Ethiopia is intended to serve as MEDHIN's operating base for developing controlled breeding capacity, scientific knowledge and future research relationships. The long-term ambition is to connect Ethiopian scientific capability with qualified pharmaceutical, biomedical and international research networks.

Scientific / biotechnology vision

From biological resource to research platform

MEDHIN's vision is to establish a professionally managed platform where scorpion biology and venom can be studied through documented, controlled and lawful processes. The emphasis is on research value, quality, traceability and collaboration—not simply animal production.

Long-term goals

Scale only when science and regulation support it

MEDHIN's long-term goals include developing a controlled breeding population, establishing reliable venom-production capability, strengthening laboratory and documentation systems, supporting research partnerships and building a scalable Ethiopian biotechnology platform.

1,000,000

Long-term strategic aspiration only. This is not a current population, approved stocking limit, biological forecast or government authorization.

The project

Venom biotechnology & research.

MEDHIN is developing a controlled scorpion breeding and venom-production platform designed to support pharmaceutical and biomedical research. Each stage is intended to be documented, controlled and conducted only within applicable legal and scientific requirements.

01 / CAPTIVE BREEDING

Captive breeding

Develop a managed breeding population through documented reproductive and welfare records.

02 / HUSBANDRY

Controlled husbandry

Maintain controlled environmental, containment and care systems appropriate to the species and authorized facility.

03 / POPULATION

Population management

Track population structure, survival, maturation, reproduction and traceability over time.

04 / VENOM

Venom extraction

Plan regulated venom collection as a research activity, using qualified personnel and approved procedures.

05 / RECOVERY

Recovery

Prioritize post-collection recovery, animal welfare monitoring and documented outcomes.

06 / QUALITY

Quality control

Build traceability, standardized documentation and quality systems for any future authorized research material.

Research principle: These activities describe a planned development framework, not a statement that MEDHIN is already conducting commercial venom extraction or pharmaceutical production.
Potential research applications

A research resource for multiple scientific fields.

Potential applications are presented as areas for future investigation and collaboration, not as claims of proven treatments or direct medical products.

Pharmaceutical researchInvestigation of venom-derived molecules and biological mechanisms.
ToxinologyStudy of toxins, venom composition and biological effects.
Antimicrobial researchFuture laboratory investigation of compounds with antimicrobial activity.
Neurological researchStudy of venom components and their interaction with neurological systems.
Molecular researchInvestigation of peptides, proteins and other molecular components.
Antivenom researchPotential research support for antivenom and toxin-response science.
Biomedical researchBroader laboratory research into venom-derived biological mechanisms.
Important: For research and pharmaceutical development — not direct medical use.
Sustainability & responsible practice

Conservation-minded science, responsible by design.

MEDHIN's proposed model emphasizes controlled captive breeding and responsible scientific practice rather than dependence on unmanaged wild collection.

🦂

Controlled captive breeding

Develop populations in controlled environments with documented husbandry, reproduction and welfare records.

🌿

Minimizing wild pressure

Use captive breeding as the intended foundation for future operations, helping minimize unnecessary pressure on wild populations.

❤️

Animal welfare

Place appropriate care, monitoring, recovery and humane management at the center of the breeding and research framework.

🧪

Responsible venom collection

Any venom collection is intended to occur only under qualified, approved and documented procedures.

🔗

Traceability

Maintain records that connect animals, population management, research material and relevant documentation.

📚

Scientific documentation

Build a culture of accurate records, quality control, research transparency and continuous scientific review.

Environmental responsibility: Any future expansion should be assessed against applicable Ethiopian wildlife, environmental, animal-health and facility requirements.
Regulatory commitment

Authorization before regulated commercial activity.

MEDHIN is committed to obtaining the necessary Ethiopian governmental approvals, permits and registrations before commencing regulated commercial activities.

Current status

REGULATORY authorization: in progress.

The project remains subject to confirmation of applicable Ethiopian scientific, wildlife, environmental, animal-health, facility, trade and other regulatory requirements.

Commitment

Compliance is a prerequisite.

MEDHIN will not present this website as evidence of a license, permit, approval or authorization to possess, breed, extract, process, sell or export scorpions or venom.

Regulatory framework
✓Confirm species identification and regulatory classification through appropriate Ethiopian scientific and regulatory authorities.
✓Identify and obtain required permits, registrations and facility approvals before regulated operations begin.
✓Maintain documentation and traceability appropriate to future authorized research activities.
✓Scale only when legal, scientific, welfare, safety and research requirements have been demonstrated.
Partnerships

Building a network for serious scientific collaboration.

MEDHIN's future development is intended to be supported by qualified institutions rather than positioned as an agricultural farm. The focus is venom biotechnology, biomedical research and scientific collaboration.

Potential collaborators

Research ecosystem

UniversitiesAcademic research, training and scientific expertise.
Biomedical research institutionsTranslational and laboratory research capacity.
LaboratoriesAnalytical, toxicology and molecular research capabilities.
Antivenin researchersResearch into toxins, envenomation and antivenom science.
International research partnersSpecialized expertise, collaborative studies and scientific networks.
Interested in collaboration?

Partner with MEDHIN

We welcome preliminary conversations with universities, laboratories, biomedical researchers and other qualified organizations interested in venom biotechnology and responsible scientific research.

Contact Us
Leadership

The people presented for MEDHIN.

Leadership information shown here follows the project information supplied for the website.

Daniel Muhabaw Feleke
Founder / Investor

Daniel Muhabaw Feleke

Proposed Founder / Investor of the MEDHIN Commercial Deathstalker Scorpion Breeding & Venom Research Project.

Liya Kebede
Manager

Liya Kebede

Manager. The project information supplied for the website describes her as having a nursing degree.

Contact MEDHIN

Research, partnership & project enquiries.

For preliminary discussions about the project, scientific collaboration, institutional partnerships or leadership, use the contact details provided below.

Email the founder
Direct contact
Founder emailDanielmuhabaw45@gmail.com
Phone+251 978 404 124
Phone0707134049
Important: This website presents a preliminary biotechnology and research concept. It does not constitute a government license, permit, approval or authorization to possess, collect, import, breed, transport, extract, process, sell or export scorpions or venom.